Research Report: CERITER Clinical Study - Stride One

Brief summary (registry, in English)

The goal of this clinical study is to investigate the short-term impact of the use of Ceriter Stride One on the quality of gait in patients rehabilitating after a cerebrovascular accident (CVA). Stride One is a smart insole that provides real-time audio feedback (cues) to the patient when performing a certain exercise. The main questions it aims to answer are: * Will patients with a CVA show a qualitatively better gait pattern after training with a Stride One insole? * Can patients maintain this improvement in gait pattern without audio feedback at the end of the training? Participants will * Receive daily gait rehabilitation using Stride One for 1 week * The quality of the gait pattern was evaluated at the beginning and at the end of the week, with and without the use of Stride One * An additional evaluation was performed three to four days after the end of therapy without the use of Stride One * Immediately after the end of the intervention week, the patient and the treating therapist were asked about their findings regarding the use of Stride One while walking

What you commit to

• Study type: Interventional
• Participants enrolled: 10
• From 18 Dec 2023 to the primary completion date, 29 Apr 2024
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.